| Zyrtec-D Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Zyrtec-D 5 mg-120 mg | tablet, extended release | oral | 1.0 each | OTC |
| Zyrtec-D 5 mg-120 mg | tablet, extended release | oral | 1.0 each | OTC |
Market Report -- In Play (PRGO) - MSN Money
The product will be marketed by Perrigo under store brand labels and is comparable to McNeil Consumer Healthcare's recently launched Zyrtec-D ...
Thu Mar 06 13:17:44 -0500 2008
Market Report -- In Play (PRGO) - MSN Money
The product will be marketed by Perrigo under store brand labels and is comparable to McNeil Consumer Healthcare's recently launched Zyrtec-D ...
Thu Mar 06 13:17:44 -0500 2008
Perrigo Company to Market Over-the-Counter Cetirizine ... - Earthtimes
The product will be marketed by Perrigo under store brand labels and is comparable to McNeil Consumer Healthcare's recently launched Zyrtec-D(R) ...
Thu Mar 06 13:02:22 -0500 2008
cetirizine - Cetirizine is a metabolite of hydroxyzine and a selective peripheral histamine H1-receptor antagonist. It is used for symptomatic treatment of seasonal and perennial allergic rhinitis and for chronic urticaria. (NCI)
pseudoephedrine hydrochloride - The hydrochloride salt form of pseudoephedrine, a phenethylamine and an diastereomer of ephedrine with sympathomimetic property. Pseudoephedrine hydrochloride displaces norepinephrine from storage vesicles in presynaptic neurones, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors. It also has weak direct agonist activity at alpha- and beta- adrenergic receptors. Receptor stimulation results in vasoconstriction and decreases nasal and sinus congestion.